Table 1.
Baseline demographic and clinical characteristics for the 66 patients analyzed.
| Variables | All Patients | INSTI Group | Non-INSTI Group | p-Value |
|---|---|---|---|---|
| Number of patients (%) | 66 (100) | 45 (68.18) | 21 (31.82) | |
| Mean Age (±SD), years | 26.67 (±4.79) | 26.53 (±4.79) | 26.95 (±4.90) | 0.853 |
| Male Gender (%) | 33 (50.00) | 23 (51.11) | 10 (47.62) | 0.792 |
| Mean weight (±SD), kg | 58.65 (12.51) | 59.63 (13.66) | 56.56 (9.54) | 0.711 |
| Caucasian ethnicity | 61 (92.42) | 42 (93.33) | 19 (90.48) | 0.683 |
| Mean Born weight (±SD), grams | 2863.40 (±725.64) N = 47 |
2845.15 (±636.62) N = 33 |
2906.43 (±928.83) N = 14 |
0.972 |
| Mean CD4+T-cell count, cells/mm3 (at last clinical evaluation) | 817.68 (±335.21) N = 65 |
770.98 (±348.18) N = 44 |
915.52 (±289.94) | 0.059 |
INSTI: integrase strand transfer inhibitor; SD: standard deviation.